University Hospitals Birmingham's brain tumour centre has been recognised as a Tessa Jowell Centre of Excellence following rigorous expert-led assessments by the Tessa Jowell Brain Cancer Mission.
A UK study sponsored and run by the University of Birmingham has launched aiming to better understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions including cancer.
A study led by the University of Birmingham has found combining advanced imaging and artificial intelligence techniques can accurately classify the characteristics of common types of childhood brain tumours.
Professor Pam Kearns, Director of the Institute of Cancer and Genomic Sciences, writes an opinion piece on how COVID-19 has replaced cancer as 'the big C'.
Patients' chances of survival after cancer surgery is strongly linked with the standard of post-operation hospital care, a major international study suggests.
Latest study found that around a third of healthcare workers reported increased symptoms of anxiety and depression following the initial COVID-19 pandemic peak.
Leading cancer experts at the University of Birmingham have solved a long-standing question of how various types of mutations in just one gene cause different types of disease.
A new and less invasive treatment developed by researchers is safer than standard major surgery for early-stage rectal cancer, giving patients a better quality of life with fewer life-altering side effects.
University of Birmingham researchers have developed a new COVID-19 test that reduces testing time from 30 minutes to less than 5 and delivers accurate results.
Cancer Research UK has announced the appointment of Professor Pamela Kearns, Director of the University of Birmingham's Institute of Cancer and Genomic Sciences, as a Trustee and Member.